Document is current
Any future updates will be listed below
-
Authors
Dalvie, Neil C.
Lorgeree, Timothy R.
Yang, Yuchen
Rodriguez-Aponte, Sergio A.
Whittaker, Charles A.
Hinckley, Joshua A.
Clark, John J.
Del Rosario, Amanda M.
Love, Kerry R.
Love, J. Christopher
-
Funding
Funding for this research was provided by:
AltHost Consortium
Ludwig Center at MIT's Koch Institute
National Cancer Institute (P30-CA14051, P30-CA14051)
Massachusetts Institute of Technology
- License Information
-
More Information
Article History
Received: 29 April 2024
Accepted: 19 June 2024
First Online: 31 July 2024
Declarations
:
: Not applicable. (All yeasts consented to this study).
: Not applicable.
: K.R.L is a current employee at Sunflower Therapeutics PBC. J.C.L. has interests in Amplifyer Bio, Sunflower Therapeutics PBC, Honeycomb Biotechnologies, OneCyte Biotechnologies, QuantumCyte, and Repligen. J.C.L’s interests are reviewed and managed under MIT’s policies for potential conflicts of interest.
